Immunexpress Releases Key Performance Data on SeptiCyte™ LAB in PLOS Medicine Publication

Immunexpress.com

SEATTLE, Dec. 8, 2015 /PRNewswire/ — Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, announced today the publication of the discovery and validation of the SeptiCyte® Lab test for sepsis in PLOS Medicine. SeptiCyte® Lab is a rapid molecular assay that measures a patient’s gene expression level to differentiate between sepsis…

Read More